Menu
  • The Barrow Neuroplex
  • Find a Doctor
  • International Patients
  • Contact Us
  • Patients & Families
  • Education
  • Research
  • Departments & People
  • News & Stories
  • Transfer a Patient
  • NeuroSense NST001

    Enrollment Information

    Call (602) 406-1466 or E-Mail [email protected]

    The purpose of this study is to provide interested ALS patients with Ciprofloxacin/Celecoxib fixed dose combination, while assessing safety and tolerability, routine disease progression measures, and change in biomarkers. There are six visits required for this study. These visits will happen at the same time as regularly scheduled visits to the BNI ALS Multidisciplinary Clinic, and will occur approximately every 3 months. Overall, participants may be in the research study for about 15 months.

    Principal Investigators: Jeremy Shefner, MD, PhD

    About Barrow Neurological Institute
    Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.